-
1 Comment
Leisure Acquisition Corp is currently in a long term uptrend where the price is trading 12.1% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
Leisure Acquisition Corp's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has increased by 94.3% to $-75K since the same quarter in the previous year.
Finally, its free cash flow grew by 7.1% to $-396K since the same quarter in the previous year.
Based on the above factors, Leisure Acquisition Corp gets an overall score of 4/5.
| ISIN | US2936021086 |
|---|---|
| Industry | Shell Companies |
| Sector | Financial Services |
| CurrencyCode | USD |
| Exchange | PINK |
| Dividend Yield | 0.0% |
|---|---|
| Market Cap | 90M |
| Beta | -0.11 |
| PE Ratio | 118.77 |
| Target Price | None |
Ensysce Biosciences, Inc. operates as a biotechnology company that develops abuse-resistant drug technologies. It offers TAAP, a trypsin-activated abuse protection technology that prevents abuse through a two-step internal trypsin-activation process to meet the medical needs of patients living with chronic pain; and MPAR, a multi-pill abuse resistant technology that provides a layer of protection for overdose. The company was incorporated in 2003 and is based in La Jolla, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for LACQ using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
